Analysts’ price target changes for Tuesday, November 11th:
Archer Aviation (NYSE:ACHR) had its price target trimmed by Canaccord Genuity Group Inc. from $13.00 to $12.00. They currently have a buy rating on the stock.
Albertsons Companies (NYSE:ACI) had its price target cut by Evercore ISI from $22.00 to $21.00. The firm currently has an in-line rating on the stock.
Adaptive Biotechnologies (NASDAQ:ADPT) had its price target boosted by Morgan Stanley from $11.00 to $16.00. Morgan Stanley currently has an equal weight rating on the stock.
Aercap (NYSE:AER) had its price target increased by Susquehanna from $134.00 to $157.00. They currently have a positive rating on the stock.
Aercap (NYSE:AER) had its target price boosted by Morgan Stanley from $120.00 to $150.00. They currently have an equal weight rating on the stock.
Akamai Technologies (NASDAQ:AKAM) had its price target raised by Citigroup Inc. from $85.00 to $88.00. Citigroup Inc. currently has a neutral rating on the stock.
Albemarle (NYSE:ALB) had its target price raised by Evercore ISI from $88.00 to $100.00. They currently have an in-line rating on the stock.
Albemarle (NYSE:ALB) had its target price boosted by Wells Fargo & Company from $90.00 to $100.00. They currently have an equal weight rating on the stock.
Albemarle (NYSE:ALB) had its target price increased by Deutsche Bank Aktiengesellschaft from $95.00 to $110.00. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.
Alamo Group (NYSE:ALG) had its target price cut by DA Davidson from $225.00 to $190.00. DA Davidson currently has a neutral rating on the stock.
Allstate (NYSE:ALL) had its target price increased by Keefe, Bruyette & Woods from $246.00 to $250.00. The firm currently has an outperform rating on the stock.
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its target price boosted by Wells Fargo & Company from $395.00 to $479.00. They currently have an equal weight rating on the stock.
Amgen (NASDAQ:AMGN) had its price target boosted by Deutsche Bank Aktiengesellschaft from $280.00 to $285.00. The firm currently has a hold rating on the stock.
Amazon.com (NASDAQ:AMZN) had its target price increased by Daiwa Capital Markets from $254.00 to $300.00. They currently have a buy rating on the stock.
AnaptysBio (NASDAQ:ANAB) had its target price reduced by HC Wainwright from $59.00 to $52.00. The firm currently has a buy rating on the stock.
Antofagasta (LON:ANTO) had its target price raised by Canaccord Genuity Group Inc. from GBX 2,125 to GBX 3,165. They currently have a buy rating on the stock.
APA (NASDAQ:APA) had its target price boosted by JPMorgan Chase & Co. from $25.00 to $28.00. They currently have a neutral rating on the stock.
Air Products and Chemicals (NYSE:APD) had its target price trimmed by Evercore ISI from $375.00 to $325.00. They currently have an outperform rating on the stock.
American Public Education (NASDAQ:APEI) had its target price increased by B. Riley from $37.00 to $40.00. The firm currently has a buy rating on the stock.
Appian (NASDAQ:APPN) had its price target boosted by Morgan Stanley from $29.00 to $45.00. They currently have an equal weight rating on the stock.
Arcos Dorados (NYSE:ARCO) had its price target trimmed by JPMorgan Chase & Co. from $8.80 to $8.70. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Arcturus Therapeutics (NASDAQ:ARCT) had its target price trimmed by HC Wainwright from $12.00 to $9.00. They currently have a neutral rating on the stock.
Arcturus Therapeutics (NASDAQ:ARCT) had its price target trimmed by Piper Sandler from $140.00 to $72.00. The firm currently has an overweight rating on the stock.
Ashland (NYSE:ASH) had its target price reduced by Evercore ISI from $62.00 to $53.00. Evercore ISI currently has an in-line rating on the stock.
Ashland (NYSE:ASH) had its price target lowered by Wells Fargo & Company from $52.00 to $51.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Barclays (LON:BARC) had its price target increased by JPMorgan Chase & Co. from GBX 500 to GBX 525. They currently have an outperform rating on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its target price boosted by Wells Fargo & Company from $76.00 to $84.00. Wells Fargo & Company currently has an overweight rating on the stock.
Bicara Therapeutics (NASDAQ:BCAX) had its price target raised by Wells Fargo & Company from $8.00 to $11.00. The firm currently has an equal weight rating on the stock.
Banco De Chile (NYSE:BCH) had its price target boosted by The Goldman Sachs Group, Inc. from $31.00 to $35.00. They currently have a neutral rating on the stock.
BKV (NYSE:BKV) had its price target boosted by Susquehanna from $32.00 to $33.00. They currently have a positive rating on the stock.
BKV (NYSE:BKV) had its price target raised by KeyCorp from $25.00 to $30.00. The firm currently has an overweight rating on the stock.
Beachbody (NASDAQ:BODI) had its price target increased by Canaccord Genuity Group Inc. from $7.00 to $9.00. The firm currently has a buy rating on the stock.
BellRing Brands (NYSE:BRBR) had its target price reduced by Morgan Stanley from $58.00 to $43.00. Morgan Stanley currently has an overweight rating on the stock.
Bitdeer Technologies Group (NASDAQ:BTDR) had its target price lowered by HC Wainwright from $32.00 to $30.00. The firm currently has a buy rating on the stock.
Bitdeer Technologies Group (NASDAQ:BTDR) had its target price raised by Rosenblatt Securities from $20.00 to $30.00. Rosenblatt Securities currently has a buy rating on the stock.
Baldwin Insurance Group (NASDAQ:BWIN) had its target price raised by BMO Capital Markets from $33.00 to $34.00. They currently have a market perform rating on the stock.
Blackstone Secured Lending Fund (NYSE:BXSL) had its target price trimmed by Wells Fargo & Company from $28.00 to $26.00. The firm currently has an equal weight rating on the stock.
Blackstone Secured Lending Fund (NYSE:BXSL) had its price target cut by Keefe, Bruyette & Woods from $30.00 to $29.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Camtek (NASDAQ:CAMT) had its target price boosted by Evercore ISI from $100.00 to $130.00. The firm currently has an outperform rating on the stock.
Maplebear (NASDAQ:CART) had its target price trimmed by Benchmark Co. from $67.00 to $60.00. Benchmark Co. currently has a buy rating on the stock.
Maplebear (NASDAQ:CART) had its target price reduced by Needham & Company LLC from $66.00 to $50.00. They currently have a buy rating on the stock.
Maplebear (NASDAQ:CART) had its target price cut by JPMorgan Chase & Co. from $65.00 to $55.00. The firm currently has an overweight rating on the stock.
Celanese (NYSE:CE) had its price target trimmed by Evercore ISI from $75.00 to $45.00. Evercore ISI currently has an in-line rating on the stock.
Carlyle Secured Lending (NASDAQ:CGBD) had its price target lowered by B. Riley from $14.50 to $13.00. B. Riley currently has a neutral rating on the stock.
Chemring Group (LON:CHG) had its target price raised by Berenberg Bank from GBX 630 to GBX 670. The firm currently has a buy rating on the stock.
Celldex Therapeutics (NASDAQ:CLDX) had its price target trimmed by Barclays PLC from $25.00 to $21.00. Barclays PLC currently has an underweight rating on the stock.
Calumet (NASDAQ:CLMT) had its target price boosted by TD Cowen from $15.00 to $18.00. They currently have a hold rating on the stock.
CNH Industrial (NYSE:CNH) had its target price trimmed by DA Davidson from $13.00 to $10.00. DA Davidson currently has a neutral rating on the stock.
Cogent Biosciences (NASDAQ:COGT) had its target price raised by Robert W. Baird from $14.00 to $34.00. They currently have a neutral rating on the stock.
CommScope (NASDAQ:COMM) had its target price raised by Bank of America Corporation from $20.00 to $23.50. They currently have a buy rating on the stock.
Cencora (NYSE:COR) had its price target increased by Wells Fargo & Company from $354.00 to $405.00. The firm currently has an overweight rating on the stock.
Cencora (NYSE:COR) had its price target raised by JPMorgan Chase & Co. from $344.00 to $417.00. They currently have an overweight rating on the stock.
Circle Internet Group (NYSE:CRCL) had its price target increased by JPMorgan Chase & Co. from $93.00 to $94.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
CRH (LON:CRH) had its target price increased by JPMorgan Chase & Co. from GBX 9,645 to £102.56. The firm currently has an overweight rating on the stock.
CRH (NYSE:CRH) had its target price increased by JPMorgan Chase & Co. from $130.00 to $135.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Charles River Laboratories International (NYSE:CRL) had its price target boosted by Morgan Stanley from $170.00 to $185.00. The firm currently has an equal weight rating on the stock.
CRISPR Therapeutics (NASDAQ:CRSP) had its target price trimmed by Robert W. Baird from $52.00 to $44.00. They currently have a neutral rating on the stock.
CoreWeave (NASDAQ:CRWV) had its target price lowered by Evercore ISI from $175.00 to $160.00. Evercore ISI currently has an outperform rating on the stock.
CoreWeave (NASDAQ:CRWV) had its price target reduced by Bank of America Corporation from $168.00 to $140.00. They currently have a neutral rating on the stock.
CoreWeave (NASDAQ:CRWV) had its price target increased by Morgan Stanley from $91.00 to $99.00. They currently have an equal weight rating on the stock.
CoreWeave (NASDAQ:CRWV) had its target price trimmed by Macquarie from $140.00 to $115.00. Macquarie currently has a neutral rating on the stock.
Cytek Biosciences (NASDAQ:CTKB) had its target price cut by Piper Sandler from $8.00 to $7.50. The firm currently has an overweight rating on the stock.
CytomX Therapeutics (NASDAQ:CTMX) had its price target boosted by HC Wainwright from $5.00 to $10.00. The firm currently has a buy rating on the stock.
Corteva (NYSE:CTVA) had its target price trimmed by Wells Fargo & Company from $80.00 to $77.00. The firm currently has an overweight rating on the stock.
Cytokinetics (NASDAQ:CYTK) had its price target increased by Royal Bank Of Canada from $82.00 to $87.00. They currently have an outperform rating on the stock.
Delek US (NYSE:DK) had its price target increased by TD Cowen from $28.00 to $36.00. TD Cowen currently has a hold rating on the stock.
Delek US (NYSE:DK) had its target price raised by Mizuho from $37.00 to $45.00. Mizuho currently has an outperform rating on the stock.
Dollar Tree (NASDAQ:DLTR) had its target price raised by Evercore ISI from $100.00 to $104.00. They currently have an in-line rating on the stock.
Viant Technology (NASDAQ:DSP) had its price target lowered by Citizens Jmp from $18.00 to $16.00. The firm currently has a market outperform rating on the stock.
Eastman Chemical (NYSE:EMN) had its target price lowered by Evercore ISI from $75.00 to $70.00. They currently have an in-line rating on the stock.
EOG Resources (NYSE:EOG) had its target price cut by Wells Fargo & Company from $127.00 to $126.00. They currently have an overweight rating on the stock.
Eos Energy Enterprises (NASDAQ:EOSE) had its price target raised by B. Riley from $8.00 to $12.00. B. Riley currently has a neutral rating on the stock.
EPAM Systems (NYSE:EPAM) had its target price raised by Mizuho from $225.00 to $228.00. They currently have an outperform rating on the stock.
eToro Group (NASDAQ:ETOR) had its target price raised by Bank of America Corporation from $50.00 to $55.00. The firm currently has a neutral rating on the stock.
eToro Group (NASDAQ:ETOR) had its price target reduced by Needham & Company LLC from $76.00 to $68.00. The firm currently has a buy rating on the stock.
Exact Sciences (NASDAQ:EXAS) had its target price raised by Piper Sandler from $70.00 to $80.00. The firm currently has an overweight rating on the stock.
Exodus Movement (NYSEAMERICAN:EXOD) had its price target lowered by Benchmark Co. from $58.00 to $42.00. Benchmark Co. currently has a buy rating on the stock.
Eagle Materials (NYSE:EXP) had its target price cut by JPMorgan Chase & Co. from $245.00 to $230.00. They currently have a neutral rating on the stock.
Expedia Group (NASDAQ:EXPE) had its target price raised by Citigroup Inc. from $206.00 to $281.00. The firm currently has a neutral rating on the stock.
4D Molecular Therapeutics (NASDAQ:FDMT) had its price target increased by Royal Bank Of Canada from $26.00 to $32.00. They currently have an outperform rating on the stock.
4D Molecular Therapeutics (NASDAQ:FDMT) had its target price raised by Chardan Capital from $25.00 to $26.00. They currently have a buy rating on the stock.
Fulgent Genetics (NASDAQ:FLGT) had its price target raised by Piper Sandler from $21.00 to $30.00. The firm currently has a neutral rating on the stock.
Floor & Decor (NYSE:FND) had its price target reduced by Evercore ISI from $75.00 to $65.00. The firm currently has an in-line rating on the stock.
Global Business Travel Group (NYSE:GBTG) had its price target boosted by Morgan Stanley from $7.00 to $8.00. They currently have an equal weight rating on the stock.
GoodRx (NASDAQ:GDRX) had its price target cut by JPMorgan Chase & Co. from $6.00 to $5.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Gemini Space Station (NASDAQ:GEMI) had its target price reduced by Needham & Company LLC from $42.00 to $35.00. They currently have a buy rating on the stock.
Global Partners (NYSE:GLP) had its target price reduced by Stifel Nicolaus from $53.00 to $45.00. They currently have a hold rating on the stock.
Global Medical REIT (NYSE:GMRE) had its target price cut by Robert W. Baird from $45.00 to $41.00. They currently have a neutral rating on the stock.
Granite Point Mortgage Trust (NYSE:GPMT) had its price target lowered by Keefe, Bruyette & Woods from $3.00 to $2.75. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Grove Collaborative (NYSE:GROV) had its price target raised by Canaccord Genuity Group Inc. from $1.50 to $2.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Ferroglobe (NASDAQ:GSM) had its target price trimmed by B. Riley from $8.00 to $6.00. B. Riley currently has a buy rating on the stock.
Granite Construction (NYSE:GVA) had its price target increased by DA Davidson from $125.00 to $130.00. They currently have a buy rating on the stock.
Health Catalyst (NASDAQ:HCAT) had its price target cut by Stifel Nicolaus from $4.50 to $3.75. Stifel Nicolaus currently has a hold rating on the stock.
Health Catalyst (NASDAQ:HCAT) had its target price cut by Wells Fargo & Company from $6.00 to $5.00. The firm currently has an overweight rating on the stock.
Home Depot (NYSE:HD) had its price target cut by Wells Fargo & Company from $450.00 to $435.00. They currently have an overweight rating on the stock.
Hologic (NASDAQ:HOLX) had its price target boosted by Morgan Stanley from $69.00 to $76.00. The firm currently has an equal weight rating on the stock.
Honeywell International (NASDAQ:HON) had its target price lowered by HSBC Holdings plc from $290.00 to $266.00. HSBC Holdings plc currently has a buy rating on the stock.
Anywhere Real Estate (NYSE:HOUS) had its price target increased by Keefe, Bruyette & Woods from $4.50 to $11.00. They currently have a market perform rating on the stock.
Hancock Whitney (NASDAQ:HWC) had its target price increased by Keefe, Bruyette & Woods from $64.00 to $65.00. They currently have a market perform rating on the stock.
IDEAYA Biosciences (NASDAQ:IDYA) had its target price boosted by Mizuho from $44.00 to $46.00. The firm currently has an outperform rating on the stock.
Ironwood Pharmaceuticals (NASDAQ:IRWD) had its price target boosted by Wells Fargo & Company from $1.00 to $3.00. They currently have an equal weight rating on the stock.
KalVista Pharmaceuticals (NASDAQ:KALV) had its target price reduced by Citizens Jmp from $29.00 to $28.00. Citizens Jmp currently has a market outperform rating on the stock.
Kelly Services (NASDAQ:KELYA) had its target price lowered by Barrington Research from $25.00 to $16.00. They currently have an outperform rating on the stock.
KKR & Co. Inc. (NYSE:KKR) had its price target boosted by Barclays PLC from $151.00 to $154.00. The firm currently has an overweight rating on the stock.
Kinder Morgan (NYSE:KMI) had its price target boosted by Stifel Nicolaus from $29.00 to $30.00. Stifel Nicolaus currently has a hold rating on the stock.
Keros Therapeutics (NASDAQ:KROS) had its target price reduced by Wells Fargo & Company from $26.00 to $23.00. The firm currently has an overweight rating on the stock.
Klaviyo (NYSE:KVYO) had its price target reduced by Macquarie from $37.00 to $30.00. The firm currently has a neutral rating on the stock.
Lowe’s Companies (NYSE:LOW) had its target price cut by Wells Fargo & Company from $290.00 to $280.00. They currently have an overweight rating on the stock.
Lowe’s Companies (NYSE:LOW) had its target price trimmed by Evercore ISI from $245.00 to $240.00. They currently have an in-line rating on the stock.
LyondellBasell Industries (NYSE:LYB) had its price target cut by Evercore ISI from $65.00 to $57.00. They currently have an in-line rating on the stock.
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its price target raised by HC Wainwright from $500.00 to $568.00. The firm currently has a buy rating on the stock.
MetLife (NYSE:MET) had its target price lowered by Keefe, Bruyette & Woods from $92.00 to $90.00. They currently have an outperform rating on the stock.
MeiraGTx (NASDAQ:MGTX) had its target price raised by Piper Sandler from $28.00 to $30.00. Piper Sandler currently has an overweight rating on the stock.
Martin Marietta Materials (NYSE:MLM) had its price target increased by JPMorgan Chase & Co. from $670.00 to $700.00. They currently have a neutral rating on the stock.
Martin Marietta Materials (NYSE:MLM) had its price target boosted by Stifel Nicolaus from $637.00 to $681.00. Stifel Nicolaus currently has a buy rating on the stock.
Mineralys Therapeutics (NASDAQ:MLYS) had its price target increased by Wells Fargo & Company from $50.00 to $55.00. The firm currently has an overweight rating on the stock.
monday.com (NASDAQ:MNDY) had its target price lowered by Robert W. Baird from $240.00 to $210.00. They currently have an outperform rating on the stock.
monday.com (NASDAQ:MNDY) had its target price cut by DA Davidson from $275.00 to $250.00. DA Davidson currently has a buy rating on the stock.
monday.com (NASDAQ:MNDY) had its target price lowered by Piper Sandler from $275.00 to $250.00. They currently have an overweight rating on the stock.
monday.com (NASDAQ:MNDY) had its price target trimmed by Bank of America Corporation from $205.00 to $195.00. Bank of America Corporation currently has a neutral rating on the stock.
monday.com (NASDAQ:MNDY) had its price target reduced by Canaccord Genuity Group Inc. from $255.00 to $230.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
monday.com (NASDAQ:MNDY) had its price target trimmed by Morgan Stanley from $260.00 to $236.00. The firm currently has an overweight rating on the stock.
monday.com (NASDAQ:MNDY) had its price target lowered by JPMorgan Chase & Co. from $285.00 to $230.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
monday.com (NASDAQ:MNDY) had its price target trimmed by Barclays PLC from $258.00 to $202.00. They currently have an overweight rating on the stock.
monday.com (NASDAQ:MNDY) had its target price trimmed by Wells Fargo & Company from $260.00 to $200.00. Wells Fargo & Company currently has an overweight rating on the stock.
MannKind (NASDAQ:MNKD) had its price target lowered by Royal Bank Of Canada from $8.00 to $7.50. Royal Bank Of Canada currently has an outperform rating on the stock.
MannKind (NASDAQ:MNKD) had its target price trimmed by Wells Fargo & Company from $10.00 to $8.00. They currently have an overweight rating on the stock.
Myriad Genetics (NASDAQ:MYGN) had its price target lowered by Piper Sandler from $9.00 to $8.50. Piper Sandler currently has an overweight rating on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its target price lowered by Morgan Stanley from $178.00 to $173.00. The firm currently has an overweight rating on the stock.
Norwegian Cruise Line (NYSE:NCLH) had its target price lowered by The Goldman Sachs Group, Inc. from $27.00 to $23.00. The firm currently has a buy rating on the stock.
Nkarta (NASDAQ:NKTX) had its target price cut by Stifel Nicolaus from $12.00 to $11.00. They currently have a buy rating on the stock.
Natera (NASDAQ:NTRA) had its target price increased by Piper Sandler from $220.00 to $230.00. Piper Sandler currently has an overweight rating on the stock.
Natera (NASDAQ:NTRA) had its price target boosted by Morgan Stanley from $195.00 to $220.00. They currently have an overweight rating on the stock.
Nexstar Media Group (NASDAQ:NXST) had its price target trimmed by Deutsche Bank Aktiengesellschaft from $229.00 to $225.00. The firm currently has a buy rating on the stock.
Owens Corning (NYSE:OC) had its target price trimmed by JPMorgan Chase & Co. from $157.00 to $113.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Oculis (NASDAQ:OCS) had its target price boosted by HC Wainwright from $36.00 to $42.00. The firm currently has a buy rating on the stock.
Organon & Co. (NYSE:OGN) had its target price cut by Morgan Stanley from $10.00 to $9.00. Morgan Stanley currently has an equal weight rating on the stock.
Organon & Co. (NYSE:OGN) had its price target trimmed by JPMorgan Chase & Co. from $14.00 to $12.00. The firm currently has an underweight rating on the stock.
Outset Medical (NASDAQ:OM) had its target price lowered by Royal Bank Of Canada from $22.00 to $17.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Outset Medical (NASDAQ:OM) had its price target lowered by BTIG Research from $39.00 to $17.00. The firm currently has a buy rating on the stock.
ON24 (NYSE:ONTF) had its target price increased by Canaccord Genuity Group Inc. from $5.00 to $6.00. They currently have a hold rating on the stock.
ON24 (NYSE:ONTF) had its price target increased by Robert W. Baird from $5.00 to $6.00. Robert W. Baird currently has a neutral rating on the stock.
Pacific Biosciences of California (NASDAQ:PACB) had its target price increased by Piper Sandler from $1.50 to $2.00. They currently have a neutral rating on the stock.
Par Pacific (NYSE:PARR) had its price target increased by Mizuho from $40.00 to $45.00. The firm currently has a neutral rating on the stock.
Progyny (NASDAQ:PGNY) had its price target raised by JPMorgan Chase & Co. from $25.00 to $26.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Pagaya Technologies (NASDAQ:PGY) had its price target raised by Canaccord Genuity Group Inc. from $36.00 to $39.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Palomar (NASDAQ:PLMR) had its target price boosted by Keefe, Bruyette & Woods from $164.00 to $170.00. The firm currently has an outperform rating on the stock.
Planet Fitness (NYSE:PLNT) had its price target raised by Macquarie from $105.00 to $110.00. They currently have a neutral rating on the stock.
Plug Power (NASDAQ:PLUG) had its target price boosted by Canaccord Genuity Group Inc. from $1.25 to $2.50. They currently have a hold rating on the stock.
Outdoor (NASDAQ:POWW) had its target price increased by Lake Street Capital from $2.00 to $2.50. Lake Street Capital currently has a buy rating on the stock.
PPG Industries (NYSE:PPG) had its price target cut by Evercore ISI from $145.00 to $112.00. Evercore ISI currently has an in-line rating on the stock.
Primerica (NYSE:PRI) had its target price cut by Keefe, Bruyette & Woods from $320.00 to $315.00. The firm currently has a market perform rating on the stock.
Paramount Skydance (NASDAQ:PSKY) had its target price raised by Wells Fargo & Company from $16.00 to $18.00. They currently have an equal weight rating on the stock.
Paramount Skydance (NASDAQ:PSKY) had its price target boosted by Evercore ISI from $12.00 to $14.00. The firm currently has an in-line rating on the stock.
Paramount Skydance (NASDAQ:PSKY) had its target price raised by Benchmark Co. from $16.00 to $19.00. They currently have a buy rating on the stock.
Paramount Skydance (NASDAQ:PSKY) had its target price increased by Bank of America Corporation from $11.00 to $13.00. The firm currently has an underperform rating on the stock.
Personalis (NASDAQ:PSNL) had its target price increased by BTIG Research from $11.00 to $12.00. BTIG Research currently has a buy rating on the stock.
Personalis (NASDAQ:PSNL) had its price target raised by Guggenheim from $6.00 to $12.00. They currently have a buy rating on the stock.
Personalis (NASDAQ:PSNL) had its price target boosted by Morgan Stanley from $5.00 to $9.00. The firm currently has an equal weight rating on the stock.
Peloton Interactive (NASDAQ:PTON) had its price target boosted by Macquarie from $11.00 to $12.00. The firm currently has an outperform rating on the stock.
PubMatic (NASDAQ:PUBM) had its target price boosted by B. Riley from $9.00 to $10.00. B. Riley currently has a neutral rating on the stock.
PubMatic (NASDAQ:PUBM) had its target price raised by Rosenblatt Securities from $17.00 to $20.00. They currently have a buy rating on the stock.
PubMatic (NASDAQ:PUBM) had its target price increased by Evercore ISI from $12.00 to $13.00. Evercore ISI currently has an outperform rating on the stock.
RealReal (NASDAQ:REAL) had its target price increased by Robert W. Baird from $8.00 to $13.00. The firm currently has a neutral rating on the stock.
Rockwell Automation (NYSE:ROK) had its price target raised by JPMorgan Chase & Co. from $357.00 to $400.00. They currently have a neutral rating on the stock.
RPM International (NYSE:RPM) had its target price cut by Evercore ISI from $145.00 to $125.00. Evercore ISI currently has an outperform rating on the stock.
Sunrun (NASDAQ:RUN) had its target price boosted by Wells Fargo & Company from $14.00 to $21.00. They currently have an overweight rating on the stock.
Septerna (NASDAQ:SEPN) had its target price increased by HC Wainwright from $26.00 to $30.00. The firm currently has a buy rating on the stock.
SFL (NYSE:SFL) had its target price increased by BTIG Research from $10.00 to $11.00. The firm currently has a buy rating on the stock.
Surgery Partners (NASDAQ:SGRY) had its target price lowered by Benchmark Co. from $35.00 to $30.00. They currently have a buy rating on the stock.
Surgery Partners (NASDAQ:SGRY) had its price target lowered by Royal Bank Of Canada from $35.00 to $31.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Shoals Technologies Group (NASDAQ:SHLS) had its target price boosted by Guggenheim from $8.00 to $12.00. They currently have a buy rating on the stock.
Smith & Nephew SNATS (NYSE:SNN) had its price target lowered by Canaccord Genuity Group Inc. from $36.00 to $34.00. Canaccord Genuity Group Inc. currently has a hold rating on the stock.
Synovus Financial (NYSE:SNV) had its target price raised by Barclays PLC from $62.00 to $65.00. The firm currently has an overweight rating on the stock.
Spruce Biosciences (NASDAQ:SPRB) had its target price increased by Citizens Jmp from $254.00 to $259.00. They currently have a market outperform rating on the stock.
SouthState Bank (NYSE:SSB) had its target price reduced by Barclays PLC from $128.00 to $125.00. Barclays PLC currently has an overweight rating on the stock.
Stevanato Group (NYSE:STVN) had its price target boosted by Morgan Stanley from $24.00 to $26.00. Morgan Stanley currently has an equal weight rating on the stock.
Starwood Property Trust (NYSE:STWD) had its price target cut by Wells Fargo & Company from $23.00 to $22.00. The firm currently has an outperform rating on the stock.
Seagate Technology (NASDAQ:STX) had its price target raised by TD Cowen from $270.00 to $340.00. TD Cowen currently has a buy rating on the stock.
Theravance Biopharma (NASDAQ:TBPH) had its price target raised by HC Wainwright from $15.00 to $20.00. They currently have a buy rating on the stock.
Tempus AI (NASDAQ:TEM) had its target price boosted by Morgan Stanley from $68.00 to $80.00. They currently have an overweight rating on the stock.
Tempus AI (NASDAQ:TEM) had its target price lowered by Piper Sandler from $105.00 to $80.00. They currently have a neutral rating on the stock.
Tecnoglass (NASDAQ:TGLS) had its price target trimmed by DA Davidson from $95.00 to $80.00. The firm currently has a buy rating on the stock.
TreeHouse Foods (NYSE:THS) had its price target raised by Stifel Nicolaus from $19.00 to $22.50. The firm currently has a hold rating on the stock.
TreeHouse Foods (NYSE:THS) had its target price boosted by Barclays PLC from $21.00 to $23.00. Barclays PLC currently has an equal weight rating on the stock.
Telos (NASDAQ:TLS) had its price target increased by Wedbush from $9.00 to $10.00. The firm currently has an outperform rating on the stock.
Tower Semiconductor (NASDAQ:TSEM) had its price target raised by Wedbush from $85.00 to $125.00. The firm currently has an outperform rating on the stock.
Tower Semiconductor (NASDAQ:TSEM) had its price target increased by Susquehanna from $100.00 to $135.00. They currently have a positive rating on the stock.
Tower Semiconductor (NASDAQ:TSEM) had its price target increased by Benchmark Co. from $73.00 to $120.00. Benchmark Co. currently has a buy rating on the stock.
Tyson Foods (NYSE:TSN) had its price target raised by BMO Capital Markets from $53.00 to $56.00. BMO Capital Markets currently has a market perform rating on the stock.
10x Genomics (NASDAQ:TXG) had its price target raised by Piper Sandler from $15.00 to $19.00. They currently have a neutral rating on the stock.
Ubiquiti (NYSE:UI) had its target price raised by Barclays PLC from $299.00 to $455.00. The firm currently has an underweight rating on the stock.
Marriott Vacations Worldwide (NYSE:VAC) had its price target reduced by The Goldman Sachs Group, Inc. from $63.00 to $54.00. The Goldman Sachs Group, Inc. currently has a sell rating on the stock.
Veracyte (NASDAQ:VCYT) had its target price boosted by Morgan Stanley from $28.00 to $40.00. The firm currently has an underweight rating on the stock.
Voya Financial (NYSE:VOYA) had its price target lowered by Keefe, Bruyette & Woods from $86.00 to $84.00. They currently have an outperform rating on the stock.
Viasat (NASDAQ:VSAT) had its target price increased by Needham & Company LLC from $25.00 to $45.00. The firm currently has a buy rating on the stock.
Wise (LON:WISE) had its price target trimmed by JPMorgan Chase & Co. from GBX 1,380 to GBX 1,375. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Williams-Sonoma (NYSE:WSM) had its target price increased by Wells Fargo & Company from $190.00 to $205.00. Wells Fargo & Company currently has an equal weight rating on the stock.
WAVE Life Sciences (NASDAQ:WVE) had its price target increased by Wedbush from $18.00 to $20.00. The firm currently has an outperform rating on the stock.
WAVE Life Sciences (NASDAQ:WVE) had its price target reduced by Wells Fargo & Company from $18.00 to $16.00. The firm currently has an overweight rating on the stock.
Xtant Medical (NYSEAMERICAN:XTNT) had its target price trimmed by BTIG Research from $2.00 to $1.50. BTIG Research currently has a buy rating on the stock.
Zoom Communications (NASDAQ:ZM) had its target price raised by Rosenblatt Securities from $110.00 to $115.00. Rosenblatt Securities currently has a buy rating on the stock.
Receive News & Ratings for Archer Aviation Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Archer Aviation Inc and related companies with MarketBeat.com's FREE daily email newsletter.
